Document is current

Article History

Received: 13 March 2025

Accepted: 6 May 2025

First Online: 28 May 2025

Declarations

:

: Koji Izutsu reports honoraria/fees from Janssen and Ono Pharmaceutical and research funding from AbbVie, Incyte, Bristol Myers Squibb, Novartis, Janssen, Yakult, Daiichi Sankyo, Chugai, BeiGene, and Genmab. Takahiro Kumode reports honoraria/fees from Janssen, AstraZeneca, AbbVie, Genmab, BeiGene, and Ono Pharmaceutical. Junichiro Yuda has nothing to disclose. Hirokazu Nagai reports honoraria/fees from Chugai, Janssen, Meiji Seika, and Ono Pharmaceutical and scholarship endowments/academic research funding from Chugai, AstraZeneca, Janssen, Genmab, AbbVie, Daiichi Sankyo, BeiGene, Eli Lilly, and Kyowa Kirin. Yuko Mishima reports honoraria/fees from Chugai and Roche and scholarship endowments/academic research funding from Takeda, Eisai, and Bristol Myers Squibb. Youko Suehiro reports research funding from Chugai, Genmab, Incyte, Amgen, Otsuka, AbbVie, Kyowa Kirin, and All Japan Pharma. Kazuhito Yamamoto reports honoraria/fees from AbbVie, Chugai, Eisai, HUYA, IQVIA, Janssen, Meiji Seika, Micron, Daiichi Sankyo, and Takeda and research funding from Genmab, IQVIA, and Yakult. Tomoaki Fujisaki has nothing to disclose. Kenji Ishitsuka has nothing to disclose. Kenichi Ishizawa reports honoraria/fees from Bristol Myers Squibb, Chugai, Eisai, and Novartis and research funding from Pfizer, SymBio, AbbVie, Chugai, and Zenyaku. Takayuki Ikezoe reports honoraria/fees from Chugai, Asahi Kasei, and Nippon Shinyaku; research funding from Asahi Kasei; and scholarship endowments/academic research funding from Asahi Kasei, Novartis, Alexion, Janssen, Dainippon Sumitomo, Nippon Shinyaku, Takeda, AbbVie, Incyte, Otsuka, and GSK. Momoko Nishikori reports honoraria/fees from Chugai and Janssen and research funding from SymBio. Daigo Akahane has nothing to disclose. Jiro Fujita has nothing to disclose. Pegah Jafarinasabian reports current employment at AbbVie. David Soong reports current employment and is a stockholder at Genmab. Barbara D’Angelo Månsson reports current employment and is a stockholder at Genmab. Ami Takahashi reports current employment and is a stockholder at Genmab. Elena Favaro reports current employment and is a stockholder at Genmab. Noriko Fukuhara reports honoraria/fees from Bristol Myers Squibb, Chugai, HUYA, and SymBio and research funding from AbbVie, Bayer, Bristol Myers Squibb, Chordia, Chugai, Genmab, Incyte, Kyowa Kirin, Loxo Oncology, and Takeda.